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Purpose: Nitric oxide (NO) is capable of promoting either cell death or cell survival depending on cell type and
experimental conditions. In this study, the possible effects of NO on the viability of lens epithelial cells were investigated
in an explant model used previously to identify cellular changes associated with posterior capsule opacification following
cataract surgery.
Methods: Rat lens epithelial explants prepared from weanling rats were cultured in a serum-free medium for five days
with or without the addition of the nitric oxide synthase inhibitor, L-Nω-nitro-L-arginine methyl ester (L-NAME), using
the inactive enantiomer D-NAME as a control. Alternatively, explants were cultured for nine days with or without the
NO donor, sodium nitroprusside. Explants were assessed morphologically and immunohistochemically or by determining
DNA content.
Results: In the presence of L-NAME but not in controls, progressive rounding up and detachment of cells from the lens
capsule occurred, leading to extensive cell loss. Affected cells showed apoptosis-like cell-surface blebbing and nuclear
fragmentation. Conversely, inclusion of sodium nitroprusside suppressed the morphological changes and spontaneous cell
loss that occurred when sparsely covered explants were cultured for nine days, increased cell coverage fourfold during
that period, and prevented the expression of the transdifferentiation markers α-smooth muscle actin and fibronectin. In
addition, whereas L-NAME exacerbated cell loss induced by culturing with 50 pg/ml transforming growth factor-β2,
sodium nitroprusside offered protection.
Conclusions: This study points to a previously unidentified role for NO as an endogenously produced survival factor for
lens epithelial cells, raising the possibility of using NO deprivation as a means of removing residual lens cells following
cataract surgery and thereby preventing posterior capsule opacification.
Many cells have the capacity to synthesize nitric oxide
(NO),  a  readily  diffusible,  short-lived  molecule  that  is
produced by the action of nitric oxide synthase (NOS) on L-
arginine. Two of three known cytoplasmic isoforms of NOS,
endothelial  cell  NOS  (eNOS/NOS-1)  and  neuronal  NOS
(nNOS/NOS-3), are expressed constitutively while the third,
inducible  NOS  (iNOS/NOS-2),  is  generally  expressed  in
response  to  immunological  challenge  or  some  other
pathophysiological stimulus [1,2]. Transient stimulation of
constitutive NOS activity results in relatively low levels of
NO production whereas iNOS activity can produce much
larger amounts of NO over several days [3,4]. A wide variety
of biological functions is served by controlled production of
NO, which can act both intracellularly as a second messenger
and  extracellularly  as  a  conveyor  of  information  between
cells. However, excessive NO production can result in cellular
damage via various mechanisms, which include the formation
of highly reactive free radicals such as peroxynitrite [4].
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Normal ocular tissues including the retina, ciliary body,
iris, conjunctiva, and cornea express NOS [5,6], and NO is
normally present at a low concentration in the aqueous humor
that bathes the lens [7,8]. Although there is some evidence that
constitutive levels of NO production contribute in positive
ways to normal ocular function, overproduction of NO in
response  to  induction  of  iNOS  is  generally  regarded  as
deleterious. For example, induction of iNOS and abnormal
production of NO occur in uveitis, retinitis, and glaucoma [5,
6] and in certain animal models of cataract [9-11]. Moreover,
the concentration of NO in the aqueous humor is known to be
elevated in endotoxin-induced uveitis and traumatic cataract
[8,12] and to increase with age in senile cataract patients or
following cataract surgery in the rabbit [7,12,13]. A role for
NO in the etiology of cataract has been proposed because of
its ability to modify lens proteins and/or cause or exacerbate
oxidative damage to lens cells or predispose them to such
damage [6,14-17].
Lens cells themselves appear to express NOS. NADP-
diaphorase activity, which is indicative of NOS activity, has
been detected in the rat lens epithelium [18]. In addition, iNOS
has been detected at low levels in the normal rat lens by
western  blot  analysis  and  RT–PCR  and  shown  to  be
upregulated in the lenses of rats treated with selenite in vivo
[9]. iNOS mRNA is also upregulated in human lens epithelial
cells cultured with a combination of lipopolysaccharide and
interferon-γ  [11,19].  Furthermore,  it  has  been  shown  that
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983opacification of the rat lens in selenite and hereditary cataract
models is accompanied by and apparently dependent upon the
induction of iNOS in the lens [9,10]. However, little is known
about  the  regulation  and  biological  significance  of  the
synthesis of NO by lens cells under normal conditions.
In other cell types, NO has been shown to affect cell
viability in profound and often paradoxical ways. NO may
promote either cell death or cell survival in vivo and in vitro
depending upon experimental conditions and the tissue or cell
type involved. For example, it may either promote apoptosis
or  protect  against  apoptosis  induced  by  various  means
including exposure to transforming growth factor-β (TGFβ)
or activation of the Fas pathway [4,20-25]. While progress has
been made in elucidating the diverse mechanisms involved in
determining cell fate in response to NO, the issues are complex
and not yet fully understood. Here, we report the effects of
NO on the viability of lens epithelial cells.
METHODS
Lens explants were prepared from 20-day-old to 21-day-old
Wistar rats as described previously [26,27]. The medium used
in all experiments (control medium) was serum-free medium
M199 supplemented with 0.1% BSA and antibiotics [28]. All
experimental procedures were in accordance with the ARVO
Statement on the Use of Animals in Ophthalmic and Vision
Research and approved by the Animal Ethics Committee,
University of Sydney (Sydney, Australia). HEPES at a final
concentration of 20 mM was added to the control medium
during initial pinning out of explants. After replacing the
HEPES-containing medium with 1 ml of the control medium,
explants were examined by phase contrast microscopy and
given a ‘cell coverage’ grade ranging from 0%–100%. This
was based on an estimate of the percentage of the total explant
surface covered by patches of attached, confluent cells [27,
29]. Cell coverage immediately after setting up the explants
was 57%±3% (mean±SEM). Explants were then assigned to
treatment groups matched with respect to initial cell coverage
and precultured for one day to ensure uniformly high coverage
in all treatment groups at the start of the experiment (day 0;
Figure 1). On day 0, the medium was replaced with control
medium  or  with  medium  containing  5  mM  L-Nω-nitro-L-
arginine  methyl  ester  (L-NAME),  a  widely  used  NOS
inhibitor, or its inactive enantiomer, D-NAME (both from
Sigma, St Louis, MO), readjusted to the control medium pH
with 0.5 M NaOH. Previous studies indicate that all NOS
isoforms would be inhibited at the concentration of L-NAME
used,  especially  given  that  lens  epithelial  cells  express
esterases capable of converting L-NAME to the more potent
inhibitor Nω-nitro-L-arginine [30,31]. Explants were cultured
at 37 °C in 5% CO2/95% air for five days. Cell coverage and
morphological  changes  were  monitored  daily  by  phase
contrast microscopy. On day 5, explants were fixed as whole
mounts  in  10%  neutral  buffered  formalin,  stained  with
methylene  blue-hematoxylin,  and  counterstained  with
Hoechst dye (H33342; Sigma).
Experiments were also performed to test the effects of a
classical  NO  donor,  sodium  nitroprusside  (SNP),  on  cell
survival. Explants with initial cell coverage of 20% or less
were used for these experiments because previous studies had
shown  that  sparsely  covered  explants  were  susceptible  to
spontaneous cell loss during culture in the control medium
[27]. The explants were assigned to two matched groups and
precultured for 24 h as described above and then cultured for
nine days with or without the addition of SNP (Calbiochem,
La Jolla, CA) at a final concentration of 50 μM. The medium
was replaced on day 5 of culture with or without the addition
of SNP as appropriate, and explants were monitored daily by
phase contrast microscopy. At the end of the culture period,
representative  explants  were  fixed  as  whole  mounts  in
Carnoy’s  fixative  (3:1  ethanol:acetic  acid),  and  α-smooth
muscle actin (αSMA) and fibronectin were immunolocalized
by a double-labeling technique with Hoechst counterstaining
of nuclei [32].
In  some  experiments,  recombinant  TGFβ2  (R&D
Systems, Minneapolis, MN) was included in the medium on
Figure 1. Effect of the nitric oxide synthase inhibitor L-NAME on
cell coverage in lens epithelial explants. Explants, initially matched
for cell coverage, were cultured in the control medium (CON) or in
the  control  medium  supplemented  with  L-NAME  or  with  the
negative control D-NAME at a final concentration of 5 mM. Cell
coverage was assessed daily by phase contrast microscopy. Each
value represents the mean±SEM of data from 9 to 12 explants.
Explants  cultured  with  L-NAME  had  significantly  lower  cell
coverage  than  the  corresponding  control  and  D-NAME-treated
explants on days 4 and 5 (p<0.001, Kruskal–Wallis test with Dunn’s
correction for multiple comparisons). NAME stands for Nω-nitro-L-
arginine methyl ester.
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984day 0 with or without L-NAME or SNP and explants were
cultured for two days. The final concentration of TGFβ2 was
50 pg/ml, a concentration shown previously to induce rapid
loss of cells from rat lens epithelial explants [26,27]. In some
experiments, explants were lysed at the end of the culture
period and the DNA content was determined by the PicoGreen
method as described [33].
RESULTS
Over the first three days of culture, cell coverage was virtually
100% in explants cultured in the control medium or in the
medium  containing  L-NAME  or  D-NAME  (Figure  1).
However, beyond three days of culture there was a dramatic
decrease in cell coverage in explants cultured with L-NAME
(Figure 1 and Figure 2B,E). In contrast, explants cultured in
the control medium or with D-NAME remained completely
covered  with  a  monolayer  of  cells  in  cobblestone  arrays
throughout the entire five-day culture period (Figure 1 and
Figure 2A,C,D,F).
The  progressive  denuding  of  the  lens  capsule  that
occurred in the presence of L-NAME was accompanied by an
extensive loss of cells from the explant. Indeed, 2 of the 11
explants  in  the  L-NAME-treated  group  were  completely
devoid of cells by day 5 of culture. During culture, large
numbers of cells were observed rounding up, becoming highly
refractile, and detaching from the lens capsule. This process
was  accompanied  by  cell-surface  blebbing,  especially  at
cellular margins abutting denuded regions of capsule (Figure
3A). Nuclear fragmentation, of the type observed in cells
undergoing  caspase-dependent  apoptosis  [34,35],  was
observed  in  marginal  cells  in  L-NAME-treated  explants
(Figure 2E) but not in untreated controls or D-NAME-treated
explants (Figure 2D,F). The cell loss observed in L-NAME-
treated explants (Figure 3A) was comparable in some respects
to that observed in explants cultured with 50 pg/ml TGFβ2,
although cell loss induced by TGFβ began at an earlier stage
of  culture  and  was  accompanied  by  more  extensive  cell-
surface blebbing (see Figure 3A,B). In addition, the capsular
wrinkling characteristically induced by TGFβ (Figure 3B)
[26,27,32]  was  not  apparent  in  L-NAME-treated  explants
(Figure 2B and Figure 3A).
The above experiment suggested that suppressing NOS
activity had a negative effect on cell survival. In analogous
experiments designed to determine whether the addition of an
NO donor promoted cell survival, inclusion of SNP not only
promoted cell survival but also permitted the repopulation of
the denuded lens capsule. At the end of the culture period, all
Figure 2. Histology of lens epithelial explants cultured with the nitric oxide inhibitor L-NAME. Explants were cultured in the control medium
(A and D) or in the control medium supplemented with 5 mM L-NAME (B and E) or D-NAME (C and F). Representative explants were fixed
on day 5 of culture and stained with methylene blue-hematoxylin (A-C) and Hoechst dye (D-F). Explants cultured in the control medium
(A) or the control medium with D-NAME (C) were completely covered with a monolayer of closely packed cells in the cobblestone array
typical of the normal lens epithelium whereas in the L-NAME-treated explants (B) large regions of lens capsule were denuded of cells (denoted
by an asterisk). Nuclei in explants cultured in the control medium alone and the D-NAME-treated explants were relatively uniform in shape
and evenly stained with Hoechst dye (D and F) whereas nuclei in the L-NAME-treated explants (E) showed crescent-like staining with Hoechst
dye (arrow) or nuclear fragmentation (arrowheads). The bar represents 80 μm in A-C and 35 μm in D-F. NAME stands for Nω-nitro-L-arginine
methyl ester.
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985SNP-treated  explants  were  50%–100%  covered  with
confluent cells in cobblestone arrays (Table 1; Figure 3D)
including an explant with very low initial cell coverage (<5%).
In  contrast,  most  explants  in  the  control  group  cultured
without SNP showed extensive and progressive cell loss over
the same period (Table 1; Figure 3C).
Including  SNP  in  the  medium  also  suppressed  the
capsular  wrinkling  and  cell-surface  blebbing  typically
associated with cell detachment under these conditions (Table
1).  In  the  control  group,  cells  abutting  the  denuded  lens
capsule  were  particularly  prone  to  surface-blebbing  and
detachment (Figure 3C) whereas corresponding cells in SNP-
treated explants generally remained bleb-free and extended
lamellipodia onto the lens capsule at cellular margins (not
shown).  Furthermore,  residual  cells  in  explants  that  were
cultured in the control medium for nine days exhibited specific
reactivity  for  transdifferentiation  markers,  αSMA  and
fibronectin (Figure 4A-C), a finding consistent with previous
studies  [29,32],  whereas  reactivity  for  these  markers  was
negligible  in  corresponding  explants  cultured  with  SNP
(Figure 4D-F).
In  experiments  in  which  TGFβ2  was  included  in  the
medium on day 0, L-NAME appeared to exacerbate TGFβ-
induced cell loss during the two days of culture (Table 2A)
whereas SNP again exhibited a positive effect on cell survival
(Table 2B). The latter was evidenced by the significantly
higher cell coverage and DNA content of explants cultured
with  TGFβ  plus  SNP  compared  with  those  cultured  with
TGFβ alone (Table 2B). However, the cell-surface blebbing
and capsular wrinkling that generally precede cell loss were
visible in at least some regions of all explants cultured with
TGFβ plus SNP by day 2 of culture, and all these explants
became virtually devoid of cells by day 6 (not shown).
Figure 3. Effects of L-NAME, TGFβ, and SNP on the morphology of lens epithelial explants. Explants were cultured for five days with the
NOS inhibitor L-NAME (A), for two days with 50 pg/ml TGFβ2 (B), or for nine days in the control medium (C) or control medium
supplemented with the NO donor SNP (D) and then photographed by phase contrast microscopy. In explants cultured with L-NAME (A),
large regions of smooth lens capsule were visible (denoted by an asterisk) between strands of cells and clusters of bright, detached cells, and
cells abutting the capsule showed cell-surface blebbing (arrowheads). In explants cultured with TGFβ for two days (B) and sparsely covered
explants cultured in control medium without SNP for nine days (C), progressive cell loss was accompanied by extensive cell-surface blebbing
(arrowheads), and exposed regions of the lens capsule (denoted by an asterisk) exhibited wrinkling (arrow). A corresponding explant cultured
with SNP (D) became well covered with a monolayer of cells in the cobblestone array typical of the normal lens epithelium. The bar represents
80 μm in A and 100 μm in B-D. NAME stands for Nω-nitro-L-arginine methyl ester; TGF stands for transforming growth factor; and SNP
stands for sodium nitroprusside.
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986DISCUSSION
The results of this study demonstrate that suppressing NO
synthesis by including an NOS inhibitor led to an extensive
loss of cells from the lens capsule in initially well covered lens
epithelial explants and also exacerbated TGFβ-induced cell
loss. On the other hand, inclusion of an NO donor enhanced
cell survival in sparsely covered explants under conditions
that  typically  result  in  spontaneous  loss  of  cells  during
extended culture and also afforded partial protection against
TGFβ-induced  cell  loss.  Therefore,  the  results  point  to  a
previously unrecognized role for NO as a survival factor for
lens epithelial cells.
Detachment  of  cells  from  rat  lens  epithelial  explants
cultured  with  TGFβ  is  preceded  by  changes  typical  of
apoptosis  including  DNA  fragmentation,  cell-surface
blebbing, nuclear pyknosis, and nuclear fragmentation [36,
37]. Cell-surface blebbing and nuclear fragmentation were
observed in well covered explants undergoing cell loss in
response to L-NAME. They were also observed in sparsely
covered, untreated explants undergoing spontaneous cell loss,
and  in  the  latter  case,  these  changes  were  suppressed  by
including SNP in the medium. Therefore, it is likely that NO
was, at least in part, regulating lens epithelial cell survival in
these explants by influencing apoptotic pathways as is known
to occur for many other cell types [4,20,21,38].
Several growth factors and cytokines have been shown
previously to serve as survival factors for lens epithelial cells
and/or  protect  them  from  apoptosis  induced  by  serum
starvation  or  exposure  to  agents  such  as  TGFβ  and
staurosporine.  These  include  FGF  [32,39-41],  lens
epithelium-derived  growth  factor  [42],  transferrin  [43],
insulin-like growth factor-1 [44], and growth arrest-specific
gene 6 [45]. It has also been reported previously by others that
culturing  sparsely  covered  rat  lens  epithelial  explants  in
serum-free medium is associated with poor cell survival [46],
a finding consistent with the present study (Table 1 and Figure
3C) and a previous study in this laboratory [27]. The data of
Ishizaki et al. [45] indicated that lack of diffusible survival
factor(s) produced by the lens cells themselves contributed to
cell death when cell numbers were low. They also showed that
FGF-2 was ineffective as a substitute for this survival factor.
Furthermore, it has recently been reported that lens epithelial
cells are capable of producing unidentified diffusible factor(s)
that protect them against Fas-induced apoptosis provided that
they  remain  attached  to  the  lens  capsule  or  a  collagen
substratum [47].
The finding of the present study that cell loss is largely
prevented in sparsely populated lens epithelial explants by
including a source of NO strongly suggests that cell death may
occur because of depletion of endogenously produced NO
when few lens epithelial cells are present. Moreover, because
lens epithelial cells express TGFβ and experience autocrine
TGFβ stimulation following wounding of the epithelium [48,
49],  cell  death  that  is  initiated  by  NO  deficiency  in  lens
epithelial  explants  may  be  linked  with  or  augmented  by
TGFβ-induced apoptosis. In lens epithelial cells, the latter
process  is  known  to  be  associated  with  myofibroblastic/
fibroblastic transdifferentiation [50-52]. Thus, the finding that
spontaneous cell loss during long-term culture of sparsely
covered  explants  resulted  in  the  induction  of
transdifferentiation markers is consistent with the suggestion
that stimulation by endogenous TGFβ accompanies loss of
cells due to NO deprivation. Furthermore, transdifferentiation
as well as cell loss were suppressed by including an NO donor.
NO has been shown to have the potential to exert either
harmful or beneficial effects in other cellular systems via a
variety of mechanisms [4,20,21,53]. These include both pro-
apoptotic and anti-apoptotic effects. The outcome depends not
TABLE 1. EFFECT OF THE NITRIC OXIDE DONOR SNP ON CELL SURVIVAL AND MORPHOLOGY IN LENS EPITHELIAL EXPLANTS
Treatment Without SNP With SNP p-value
Day 0
Cell coverage (%) 26±6 30±4 NS
Number of explants 8 7
Day 9
Cobblestone arrays 1 7 0.001
Coverage 50% or more 2  7* <0.01
Capsular wrinkling 8 1 0.001
Blebbing and cell loss 7 0 0.001
Sparsely covered explants were cultured with or without addition of SNP on day 0 and at change of medium on day 5. Cell
coverage values are given as the mean±SEM. Other values indicate the number of explants exhibiting a particular feature. The
p-value represents the significance of the difference between explants cultured with or without SNP using Student’s t-test to
compare cell coverage values and Fisher’s exact test to compare ratios of explants exhibiting a particular feature in the two
groups. SNP stands for sodium nitroprusside, and NS stands for not significant. The term “cobblestone arrays” indicates that
confluent patches of cells exhibiting the cobblestone array typical of the normal lens epithelium were present. The term “blebbing
and cell loss” indicates that explants exhibited cell-surface blebbing and cell detachment. The asterisk indicates that mean cell
coverage in this group was 83%±8%.
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987only on the concentration of NO to which the cells are exposed
but also on factors such as their capacity to deal with oxidative
stress and the relative abundance of other free radicals in their
environment. Generally, anti-apoptotic effects are observed at
relatively low concentrations of an NO donor (30–300 μM
SNP)  whereas  the  induction  of  apoptosis  requires  higher
concentrations (1–4 mM SNP) [54-60], although exceptions
to this general rule have been noted (see reference [61], for
example). At high concentrations and under conditions that
lead to the generation of large amounts of peroxynitrate, NO
is cytotoxic and may induce cell death by necrosis if not by
apoptosis  [38].  The  paradoxical  anti-apoptotic  and  pro-
apoptotic  effects  of  NO  at  low  and  high  concentrations,
respectively, can occur in the same cell type [54-57].
Oxidative  damage  to  the  lens,  especially  the  lens
epithelium, is thought to be a triggering factor in the etiology
of several forms of cataract, and NO is regarded as an agent
capable of contributing to such damage [6,14-17]. Consistent
with  the  latter  suggestion,  changes  that  are  indicative  of
oxidative stress and therefore potentially cataractogenic were
noted in a study in which rat lenses were exposed in vitro to
an NO donor at a high concentration (1 mM) [17]. However,
consistent with findings for other cellular systems cited above,
exposing explanted lens epithelial cells to an NO donor at a
low concentration (50 μM) in the present study promoted lens
epithelial cell survival. Furthermore, the low concentration of
SNP used in the present study also prevented fibroblastic
transdifferentiation, an early event in the etiology of certain
forms of cataract and the sight-threatening condition known
as  posterior  capsule  opacification,  a  sequela  of  cataract
surgery [36,50,52,62].
It is not known whether a low level of stimulation by NO
is  required  in  the  eye  in  situ  to  maintain  a  healthy  lens
epithelium and protect against cataractous transdifferentiation
under physiological or adverse conditions. However, NO is
known  to  be  present  in  the  lens  environment  under
physiological  conditions.  A  low  concentration  of  NO  is
present  in  the  aqueous  that  bathes  the  lens  anterior.
Furthermore,  the  lens  epithelium  and  neighboring  ocular
tissues express NOS in situ and therefore represent potential
sources of NO ( [5,7-9,18] and see Introduction).
In  the  experiments  reported  here,  the  NOS  activity
inhibited  by  L-NAME  may  have  been  baseline  activity
associated with the lens epithelium in situ. However, some
damage to the lens epithelium inevitably occurs during the
preparation of explants such as those used in the present study,
Figure 4. Effect of the nitric oxide donor SNP on immunoreactivity for αSMA and fibronectin. Sparsely covered explants were cultured for
nine days in the control medium (A-C) or in the control medium containing SNP (D-J). αSMA (B and E) and fibronectin (C and F) were then
immunolocalized in fixed whole mounts of representative explants by a double-labeling technique with Hoechst counter-staining of nuclei (A
and D). Regions of the lens capsule that became denuded of cells during culture are indicated by an asterisk. The occasional small patches of
cells that remained in explants cultured in the control medium alone (A) expressed strong reactivity for αSMA (B) and fibronectin (C).
Reactivity for the latter was present throughout the explant including denuded regions of capsule where it was often present in fibrillar form
(C, arrowheads). The region indicated by the arrow in A is given at higher magnification in the inset to show the fragmentation of nuclei.
When SNP was included during culture (D), specific reactivity for αSMA (E) and fibronectin (F) was not detectable. The bar represents 50
μm in A-F and 20 μm in inset in A. SNP stands for sodium nitroprusside, and αSMA stands for α-smooth muscle actin.
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988and it is not clear whether the rate of NO production was
influenced by such damage. Irrespective of this, the present
study  has  clearly  identified  a  new  role  for  NO  as  an
endogenously produced survival factor for lens cells with the
potential to play a role in maintaining the integrity of the lens
epithelium.
Human cataract surgery results in extensive damage to
the lens epithelium. Many lens epithelial cells are removed by
excision of the central anterior capsule and adhering lens
epithelium during this procedure. However, variable numbers
of lens epithelial cells remain in situ, attached to the annulus
of anterior lens capsule that is retained. These cells have the
potential  to  undergo  fibroblastic  transdifferentiation  and
migrate  posteriorly  into  the  visual  axis  causing  posterior
capsule opacification [49,62,63]. The present study raises the
possibility of inducing the lens epithelial cells that remain
after cataract surgery to die by restricting NO availability
through means such as inhibiting NOS production or activity
or sequestering NO. Thus, it offers a new perspective on
preventing posterior capsule opacification.
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